IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, L. E.
Right arrow Articles by D'Amore, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, L. E.
Right arrow Articles by D'Amore, P. A.

Investigative Ophthalmology & Visual Science, Vol 35, 101-111, Copyright © 1994 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Oxygen-induced retinopathy in the mouse

LE Smith, E Wesolowski, A McLellan, SK Kostyk, R D'Amato, R Sullivan and PA D'Amore
Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.

PURPOSE. To develop oxygen-induced retinopathy in the mouse with reproducible and quantifiable proliferative retinal neovascularization suitable for examining pathogenesis and therapeutic intervention for retinal neovascularization in retinopathy of prematurity (ROP) and other vasculopathologies. METHODS. One-week-old C57BL/6J mice were exposed to 75% oxygen for 5 days and then to room air. A novel fluorescein-dextran perfusion method has been developed to assess the vascular pattern. The proliferative neovascular response was quantified by counting the nuclei of new vessels extending from the retina into the vitreous in 6 microns sagittal cross-sections. Cross-sections were also stained for glial fibrillary acidic protein (GFAP). RESULTS. Fluorescein-dextran angiography delineated the entire vascular pattern, including neovascular tufts in flat-mounted retinas. Hyperoxia-induced neovascularization occurred at the junction between the vascularized and avascular retina in the mid-periphery. Retinal neovascularization occurred in all the pups between postnatal day 17 and postnatal day 21. There was a mean of 89 neovascular nuclei per cross-section of 9 eyes in hyperoxia compared to less than 1 nucleus per cross-section of 8 eyes in the normoxia control (P < 0.0001). Proliferative vessels were not associated with GFAP-positive astrocyte processes. CONCLUSIONS. The authors have described a reproducible and quantifiable mouse model of oxygen-induced retinal neovascularization that should prove useful for the study of pathogenesis of retinal neovascularization as well as for the study of medical intervention for ROP and other retinal angiopathies.


This article has been cited by other articles:


Home page
 IOVSHome page
M. H. Davies, A. J. Stempel, and M. R. Powers
MCP-1 Deficiency Delays Regression of Pathologic Retinal Neovascularization in a Model of Ischemic Retinopathy
Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 4195 - 4202.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
D. Navaratna, J. Maestas, P. G. McGuire, and A. Das
Suppression of Retinal Neovascularization With an Antagonist to Vascular Endothelial Cadherin
Arch Ophthalmol, August 1, 2008; 126(8): 1082 - 1088.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
B. Xie, J. Shen, A. Dong, M. Swaim, S. F. Hackett, L. Wyder, S. Worpenberg, S. Barbieri, and P. A. Campochiaro
An Adam15 amplification loop promotes vascular endothelial growth factor-induced ocular neovascularization
FASEB J, August 1, 2008; 22(8): 2775 - 2783.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Y. Yamaji, S. Yoshida, K. Ishikawa, A. Sengoku, K. Sato, A. Yoshida, R. Kuwahara, K. Ohuchida, E. Oki, H. Enaida, et al.
TEM7 (PLXDC1) in Neovascular Endothelial Cells of Fibrovascular Membranes from Patients with Proliferative Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3151 - 3157.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
E. M. Dioum, S. L. Clarke, K. Ding, J. J. Repa, and J. A. Garcia
HIF-2{alpha}-Haploinsufficient Mice Have Blunted Retinal Neovascularization Due to Impaired Expression of a Proangiogenic Gene Battery
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2714 - 2720.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Z. Tong, Z. Yang, S. Patel, H. Chen, D. Gibbs, X. Yang, V. S. Hau, Y. Kaminoh, J. Harmon, E. Pearson, et al.
Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications
PNAS, May 13, 2008; 105(19): 6998 - 7003.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Y. Saito, A. Uppal, G. Byfield, S. Budd, and M. E. Hartnett
Activated NAD(P)H Oxidase from Supplemental Oxygen Induces Neovascularization Independent of VEGF in Retinopathy of Prematurity Model
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1591 - 1598.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. H. Nisancioglu, W. M. Mahoney Jr., D. D. Kimmel, S. M. Schwartz, C. Betsholtz, and G. Genove
Generation and Characterization of rgs5 Mutant Mice
Mol. Cell. Biol., April 1, 2008; 28(7): 2324 - 2331.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. W. Hebbard, M. Garlatti, L. J.T. Young, R. D. Cardiff, R. G. Oshima, and B. Ranscht
T-cadherin Supports Angiogenesis and Adiponectin Association with the Vasculature in a Mouse Mammary Tumor Model
Cancer Res., March 1, 2008; 68(5): 1407 - 1416.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. J. Santulli, W. A. Kinney, S. Ghosh, B. L. DeCorte, L. Liu, R. W. A. Tuman, Z. Zhou, N. Huebert, S. E. Bursell, A. C. Clermont, et al.
Studies with an Orally Bioavailable {alpha}V Integrin Antagonist in Animal Models of Ocular Vasculopathy: Retinal Neovascularization in Mice and Retinal Vascular Permeability in Diabetic Rats
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 894 - 901.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. Dorfman, O. Dembinska, S. Chemtob, and P. Lachapelle
Early Manifestations of Postnatal Hyperoxia on the Retinal Structure and Function of the Neonatal Rat
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 458 - 466.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M.-H. Yoo, Y. H. Yoon, H. Chung, K. S. Cho, and J.-Y. Koh
Insulin Increases Retinal Hemorrhage in Mild Oxygen-Induced Retinopathy in the Rat: Inhibition by Riluzole
Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5671 - 5676.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
M. A. Zayed, W. Yuan, T. M. Leisner, D. Chalothorn, A. W. McFadden, M. D. Schaller, M. E. Hartnett, J. E. Faber, and L. V. Parise
CIB1 Regulates Endothelial Cells and Ischemia-Induced Pathological and Adaptive Angiogenesis
Circ. Res., November 26, 2007; 101(11): 1185 - 1193.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J.-J. You, C.-H. Yang, J.-S. Huang, M.-S. Chen, and C.-M. Yang
Fractalkine, a CX3C Chemokine, as a Mediator of Ocular Angiogenesis
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5290 - 5298.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
N. Matsunaga, Y. Chikaraishi, M. Shimazawa, S. Yokota, and H. Hara
Vaccinium myrtillus (Bilberry) Extracts Reduce Angiogenesis In Vitro and In Vivo
Evid. Based Complement. Altern. Med., October 27, 2007; (2007) nem151v1.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. Ruiz-Ederra and A. S. Verkman
Aquaporin-1 Independent Microvessel Proliferation in a Neonatal Mouse Model of Oxygen-Induced Retinopathy
Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4802 - 4810.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
B. Larrivee, C. Freitas, M. Trombe, X. Lv, B. DeLafarge, L. Yuan, K. Bouvree, C. Breant, R. Del Toro, N. Brechot, et al.
Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis
Genes & Dev., October 1, 2007; 21(19): 2433 - 2447.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
J. Lahdenranta, R. L. Sidman, R. Pasqualini, and W. Arap
Treatment of hypoxia-induced retinopathy with targeted proapoptotic peptidomimetic in a mouse model of disease
FASEB J, October 1, 2007; 21(12): 3272 - 3278.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
R. Lima e Silva, J. Shen, S. F. Hackett, S. Kachi, H. Akiyama, K. Kiuchi, K. Yokoi, M. C. Hatara, T. Lauer, S. Aslam, et al.
The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization
FASEB J, October 1, 2007; 21(12): 3219 - 3230.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. D. Akula, R. M. Hansen, M. E. Martinez-Perez, and A. B. Fulton
Rod Photoreceptor Function Predicts Blood Vessel Abnormality in Retinopathy of Prematurity
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4351 - 4359.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
G. Birol, S. Wang, E. Budzynski, N. D. Wangsa-Wirawan, and R. A. Linsenmeier
Oxygen distribution and consumption in the macaque retina
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1696 - H1704.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. D. Monte, M. Cammalleri, D. Martini, G. Casini, and P. Bagnoli
Antiangiogenic Role of Somatostatin Receptor 2 in a Model of Hypoxia-Induced Neovascularization in the Retina: Results from Transgenic Mice
Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3480 - 3489.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
B. Appukuttan, T. J. McFarland, M. H. Davies, L.-o. Atchaneeyasakul, Y. Zhang, B. Babra, Y. Pan, J. T. Rosenbaum, T. Acott, M. R. Powers, et al.
Identification of Novel Alternatively Spliced Isoforms of RTEF-1 within Human Ocular Vascular Endothelial Cells and Murine Retina
Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3775 - 3782.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
A. B. El-Remessy, M. Al-Shabrawey, D. H. Platt, M. Bartoli, M. A. Behzadian, N. Ghaly, N. Tsai, K. Motamed, and R. B. Caldwell
Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells
FASEB J, August 1, 2007; 21(10): 2528 - 2539.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. Yokoi, S. Kachi, H. S. Zhang, P. D. Gregory, S. K. Spratt, R. J. Samulski, and P. A. Campochiaro
Ocular Gene Transfer with Self-Complementary AAV Vectors
Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3324 - 3328.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
N. Ohba, K. Nakao, Y. Isashiki, and A. Ohba
The 100 Most Frequently Cited Articles in Ophthalmology Journals
Arch Ophthalmol, July 1, 2007; 125(7): 952 - 960.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Lofqvist, J. Chen, K. M. Connor, A. C. H. Smith, C. M. Aderman, N. Liu, J. E. Pintar, T. Ludwig, A. Hellstrom, and L. E. H. Smith
From the Cover: IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth
PNAS, June 19, 2007; 104(25): 10589 - 10594.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
H. Uusitalo-Jarvinen, T. Kurokawa, B. M. Mueller, P. Andrade-Gordon, M. Friedlander, and W. Ruf
Role of Protease Activated Receptor 1 and 2 Signaling in Hypoxia-Induced Angiogenesis
Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1456 - 1462.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
D. M. Albert, E. A. Scheef, S. Wang, F. Mehraein, S. R. Darjatmoko, C. M. Sorenson, and N. Sheibani
Calcitriol Is a Potent Inhibitor of Retinal Neovascularization
Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2327 - 2334.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
E. S. Colombo, G. Menicucci, P. G. McGuire, and A. Das
Hepatocyte Growth Factor/Scatter Factor Promotes Retinal Angiogenesis through Increased Urokinase Expression
Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1793 - 1800.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Caballero, N. Sengupta, A. Afzal, K.-H. Chang, S. Li Calzi, D. L. Guberski, T. S. Kern, and M. B. Grant
Ischemic Vascular Damage Can Be Repaired by Healthy, but Not Diabetic, Endothelial Progenitor Cells
Diabetes, April 1, 2007; 56(4): 960 - 967.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
H. Qiao, K.-H. Sonoda, Y. Ikeda, T. Yoshimura, K. Hijioka, Y.-J. Jo, Y. Sassa, C. Tsutsumi-Miyahara, Y. Hata, S. Akira, et al.
Interleukin-18 regulates pathological intraocular neovascularization
J. Leukoc. Biol., April 1, 2007; 81(4): 1012 - 1021.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
I. B. Lobov, R. A. Renard, N. Papadopoulos, N. W. Gale, G. Thurston, G. D. Yancopoulos, and S. J. Wiegand
Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting
PNAS, February 27, 2007; 104(9): 3219 - 3224.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. M. Barnett, G. W. McCollum, J. A. Fowler, J. J.-W. Duan, J. D. Kay, R.-Q. Liu, D. P. Bingaman, and J. S. Penn
Pharmacologic and Genetic Manipulation of MMP-2 and -9 Affects Retinal Neovascularization in Rodent Models of OIR
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 907 - 915.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. I. Dorrell, E. Aguilar, L. Scheppke, F. H. Barnett, and M. Friedlander
Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis
PNAS, January 16, 2007; 104(3): 967 - 972.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Z. Smit-McBride, S. L. Oltjen, M. M. LaVail, and L. M. Hjelmeland
A Strong Genetic Determinant of Hyperoxia-Related Retinal Degeneration on Mouse Chromosome 6
Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 405 - 411.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. Satofuka, A. Ichihara, N. Nagai, T. Koto, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, H. Itoh, et al.
Role of Nonproteolytically Activated Prorenin in Pathologic, but Not Physiologic, Retinal Neovascularization
Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 422 - 429.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. Murakami, K. Suzuma, H. Takagi, M. Kita, H. Ohashi, D. Watanabe, T. Ojima, M. Kurimoto, T. Kimura, A. Sakamoto, et al.
Time-Lapse Imaging of Vitreoretinal Angiogenesis Originating from Both Quiescent and Mature Vessels in a Novel Ex Vivo System
Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5529 - 5536.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
N. Kociok, S. Radetzky, T. U. Krohne, C. Gavranic, and A. M. Joussen
Pathological but Not Physiological Retinal Neovascularization Is Altered in TNF-Rp55-Receptor-Deficient Mice
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 5057 - 5065.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. Yamagata, S. L. Rook, Y. Sassa, R. C. Ma, P. Geraldes, L. Goddard, A. Clermont, B. Gao, H. Salti, R. Gundel, et al.
Bactericidal/permeability-increasing protein's signaling pathways and its retinal trophic and anti-angiogenic effects
FASEB J, October 1, 2006; 20(12): 2058 - 2067.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Z. Xu, Y. Yu, and E. J. Duh
Vascular Endothelial Growth Factor Upregulates Expression of ADAMTS1 in Endothelial Cells through Protein Kinase C Signaling.
Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 4059 - 4066.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. M. Cashman, L. Bowman, J. Christofferson, and R. Kumar-Singh
Inhibition of Choroidal Neovascularization by Adenovirus-Mediated Delivery of Short Hairpin RNAs Targeting VEGF as a Potential Therapy for AMD.
Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3496 - 3504.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
D. Checchin, F. Sennlaub, E. Levavasseur, M. Leduc, and S. Chemtob
Potential role of microglia in retinal blood vessel formation.
Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3595 - 3602.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
G. Zhang, R. G. Fahmy, N. diGirolamo, and L. M. Khachigian
JUN siRNA regulates matrix metalloproteinase-2 expression, microvascular endothelial growth and retinal neovascularisation
J. Cell Sci., August 1, 2006; 119(15): 3219 - 3226.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. Neu, A. Afzal, H. Pan, E. Gallego, N. Li, S. L. Calzi, S. Caballero, P. E. Spoerri, L. C. Shaw, and M. B. Grant
The dipeptide arg-gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3151 - 3155.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. Satofuka, A. Ichihara, N. Nagai, K. Yamashiro, T. Koto, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, et al.
Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin.
Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2686 - 2692.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
O. Tatar, E. Kaiserling, A. Adam, F. Gelisken, K. Shinoda, M. Volker, B. A. Lafaut, K. U. Bartz-Schmidt, and S. Grisanti
Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes.
Arch Ophthalmol, June 1, 2006; 124(6): 815 - 823.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. R. Harris, G. A. J. Brown, M. Jorgensen, S. Kaushal, E. A. Ellis, M. B. Grant, and E. W. Scott
Bone Marrow-Derived Cells Home to and Regenerate Retinal Pigment Epithelium after Injury
Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 2108 - 2113.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
E. Banin, M. I. Dorrell, E. Aguilar, M. R. Ritter, C. M. Aderman, A. C. H. Smith, J. Friedlander, and M. Friedlander
T2-TrpRS Inhibits Preretinal Neovascularization and Enhances Physiological Vascular Regrowth in OIR as Assessed by a New Method of Quantification
Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 2125 - 2134.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. A. Kramerov, M. Saghizadeh, H. Pan, A. Kabosova, M. Montenarh, K. Ahmed, J. S. Penn, C. K. Chan, D. R. Hinton, M. B. Grant, et al.
Expression of Protein Kinase CK2 in Astroglial Cells of Normal and Neovascularized Retina
Am. J. Pathol., May 1, 2006; 168(5): 1722 - 1736.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. L. Dorfman, O. Dembinska, S. Chemtob, and P. Lachapelle
Structural and functional consequences of trolox C treatment in the rat model of postnatal hyperoxia.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1101 - 1108.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. S. Penn, G. W. McCollum, J. M. Barnett, X. Q. Werdich, K. A. Koepke, and V. S. Rajaratnam
Angiostatic Effect of Penetrating Ocular Injury: Role of Pigment Epithelium-Derived Factor
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 405 - 414.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. Mechoulam and E. A. Pierce
Expression and Activation of STAT3 in Ischemia-Induced Retinopathy
Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4409 - 4416.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. H. Yoo, H.-J. Hyun, J.-Y. Koh, and Y. H. Yoon
Riluzole Inhibits VEGF-Induced Endothelial Cell Proliferation In Vitro and Hyperoxia-Induced Abnormal Vessel Formation In Vivo
Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4780 - 4787.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
H. Akiyama, K. A. Mohamedali, R. L. e Silva, S. Kachi, J. Shen, C. Hatara, N. Umeda, S. F. Hackett, S. Aslam, M. Krause, et al.
Vascular Targeting of Ocular Neovascularization with a Vascular Endothelial Growth Factor121/Gelonin Chimeric Protein
Mol. Pharmacol., December 1, 2005; 68(6): 1543 - 1550.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Economopoulou, K. Bdeir, D. B. Cines, F. Fogt, Y. Bdeir, J. Lubkowski, W. Lu, K. T. Preissner, H.-P. Hammes, and T. Chavakis
Inhibition of pathologic retinal neovascularization by {alpha}-defensins
Blood, December 1, 2005; 106(12): 3831 - 3838.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
G. Bergers and S. Song
The role of pericytes in blood-vessel formation and maintenance
Neuro-oncol, October 1, 2005; 7(4): 452 - 464.
[Abstract] [PDF]

Home page
 IOVSHome page
M. R. Ritter, E. Aguilar, E. Banin, L. Scheppke, H. Uusitalo-Jarvinen, and M. Friedlander
Three-Dimensional In Vivo Imaging of the Mouse Intraocular Vasculature during Development and Disease
Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3021 - 3026.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
D. Watanabe, K. Suzuma, S. Matsui, M. Kurimoto, J. Kiryu, M. Kita, I. Suzuma, H. Ohashi, T. Ojima, T. Murakami, et al.
Erythropoietin as a Retinal Angiogenic Factor in Proliferative Diabetic Retinopathy
N. Engl. J. Med., August 25, 2005; 353(8): 782 - 792.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
L. Notari, A. Miller, A. Martinez, J. Amaral, M. Ju, G. Robinson, L. E. H. Smith, and S. P. Becerra
Pigment Epithelium-Derived Factor Is a Substrate for Matrix Metalloproteinase Type 2 and Type 9: Implications for Downregulation in Hypoxia
Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2736 - 2747.
[Abstract] [Full Text] [PDF]